Literature DB >> 16511811

Searching for markers of Creutzfeldt-Jakob disease in cerebrospinal fluid by two-dimensional mapping.

Chiara Piubelli1, Michele Fiorini, Gianluigi Zanusso, Alberto Milli, Elisa Fasoli, Salvatore Monaco, Pier Giorgio Righetti.   

Abstract

Differential proteomic analysis has been performed on the cerebrospinal fluid (CSF) of six healthy and six patients suffering form sporadic Creutzfeldt-Jakob disease (sCJD), age- and sex-matched, after immuno-subtraction of albumin and immunoglobulins. These maps have revealed 28 polypeptide chains differentially modulated in the sCJD samples, of which 10 appeared to be up-regulated, the remaining 18 being down-regulated. Among those, 13 could be identified upon digestion and MALDI-TOF, MS analysis. In addition, the strong modulation of cystatin C was also confirmed by immunoblot analysis and the highly altered level of the 14-3-3 proteins that escaped detection by 2-D mapping, could be assessed by Western blots and immuno-detection of monomeric and homo- and hetero-dimeric 14-3-3 isotypes. In search for a panel of potential markers for sCJD, we highlight cystatin C, 14-3-3 proteins, transferrin, ubiquitin, Apoliprotein J and perhaps some of the still unidentified, but strongly modulated polypeptide chains detected in the differential map.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16511811     DOI: 10.1002/pmic.200500294

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  9 in total

1.  Global protein differential expression profiling of cerebrospinal fluid samples pooled from Chinese sporadic CJD and non-CJD patients.

Authors:  Cao Chen; Di Xiao; Wei Zhou; Qi Shi; Hui-Fang Zhang; Jin Zhang; Chan Tian; Jian-Zhong Zhang; Xiao-Ping Dong
Journal:  Mol Neurobiol       Date:  2013-08-04       Impact factor: 5.590

2.  Gelsolin in cerebrospinal fluid as a potential biomarker of epilepsy.

Authors:  Xi Peng; Xiaogang Zhang; Liang Wang; Qiong Zhu; Jing Luo; Wei Wang; Xuefeng Wang
Journal:  Neurochem Res       Date:  2011-07-24       Impact factor: 3.996

Review 3.  Application of "omics" to prion biomarker discovery.

Authors:  Rhiannon L C H Huzarewich; Christine G Siemens; Stephanie A Booth
Journal:  J Biomed Biotechnol       Date:  2010-03-04

4.  cNEUPRO: Novel Biomarkers for Neurodegenerative Diseases.

Authors:  Philipp Spitzer; Hans Wolfgang Klafki; Kaj Blennow; Luc Buée; Hermann Esselmann; Sanna-Kaisa Herruka; Connie Jimenez; Peter Klivenyi; Piotr Lewczuk; Juan Manuel Maler; Katrin Markus; Helmut E Meyer; Chris Morris; Thorsten Müller; Markus Otto; Lucilla Parnetti; Hilkka Soininen; Susanna Schraen; Charlotte Teunissen; Laszlo Vecsei; Henrik Zetterberg; Jens Wiltfang
Journal:  Int J Alzheimers Dis       Date:  2010-09-19

5.  Genomic and post-genomic analyses of human prion diseases.

Authors:  Maurizio Pocchiari; Anna Poleggi; Serena Principe; Silvia Graziano; Franco Cardone
Journal:  Genome Med       Date:  2009-06-22       Impact factor: 11.117

6.  Decreased CSF transferrin in sCJD: a potential pre-mortem diagnostic test for prion disorders.

Authors:  Ajay Singh; Alim J Beveridge; Neena Singh
Journal:  PLoS One       Date:  2011-03-09       Impact factor: 3.240

Review 7.  Are cerebrospinal fluid biomarkers useful in predicting the prognosis of multiple sclerosis patients?

Authors:  Alberto Gajofatto; Matilde Bongianni; Gianluigi Zanusso; Maria Donata Benedetti; Salvatore Monaco
Journal:  Int J Mol Sci       Date:  2011-11-16       Impact factor: 5.923

8.  Brain-derived proteins in the CSF: do they correlate with brain pathology in CJD?

Authors:  Constanze Boesenberg-Grosse; Walter J Schulz-Schaeffer; Monika Bodemer; Barbara Ciesielczyk; Bettina Meissner; Anna Krasnianski; Mario Bartl; Uta Heinemann; Daniela Varges; Sabina Eigenbrod; Hans A Kretzschmar; Alison Green; Inga Zerr
Journal:  BMC Neurol       Date:  2006-09-21       Impact factor: 2.474

9.  Urinary alpha1-antichymotrypsin: a biomarker of prion infection.

Authors:  Gino Miele; Harald Seeger; Denis Marino; Ralf Eberhard; Mathias Heikenwalder; Katharina Stoeck; Max Basagni; Richard Knight; Alison Green; Francesca Chianini; Rudolf P Wüthrich; Christoph Hock; Inga Zerr; Adriano Aguzzi
Journal:  PLoS One       Date:  2008-12-05       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.